ASX healthcare rises for week ending January 23, 2026 as Morgans' Scott Power says focus shifts to quarterly reporting season. ... Read More The post Scott Power: ASX healthcare lifts as focus turns ...

In this week's Business Digest, staff promotions are announced for a local firm while a local hospital system is welcoming multiple new providers.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained ...

Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...

PHILADELPHIA (WPVI) -- Most of us have heard of atrial fibrillation, commonly called AFib. The airwaves are filled with commercials for treatments. A Roxborough woman shared her struggle with it, and ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically navigated magnetic ablation catheter designed to perform cardiac ablation ...

Investing.com -- Stereotaxis (NYSE:STXS) stock surged 8.3% Tuesday after the surgical robotics company announced it received U.S. Food and Drug Administration (FDA) approval for its MAGiC Magnetic ...

Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation (PFA) platform designed to support both ventricular tachycardia (VT) and ...

TactiFlex Duo builds on Abbott’s electrophysiology portfolio with a catheter than can ablate irregular heart rhythms using ...